Over the past year, beam has significantly strengthened its industry recognition, with growing awareness of its influence and contributions. The board has expanded to 13 members, including ...

Enrollment Target for Adult Sickle Cell Disease Patients Achieved in BEACON Trial ofBEAM-101; Dosing of 30 Patients and Updated Data Expected by Mid-2025 Initial Data from Phase 1/2 Trial of BEAM-302 ...